Health
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Drug Prices
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan

Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Drug Prices
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong

Improving Payment for Primary Care: The Foundation of a High-Quality, Affordable Health Care System
Provider Payment Incentives
Improving Payment for Primary Care: The Foundation of a High-Quality, Affordable Health Care System

Successes & Opportunities in Patient-First Care
Provider Payment Incentives
Successes & Opportunities in Patient-First Care
Medicare Sustainability
AV Submits Letter Addressing Overpayments in Medicare Advantage
Drug Prices
What a Bipartisan State of the Union Looks Like
Op-Ed
Same Service, Same Price
New Chart Shows State-Level Impacts of Site Neutrality
Commercial Sector Prices
AV Submits Letter on the Proposed Rule on Operations of the No Surprises Act’s Independent Dispute Resolution Process
Clinical Trials
AV Responds to HELP Committee Request for Information on Gene Therapies
Medicare-Medicaid Integration
AV Submits Letter on Transparency and Accountability in Medicare Advantage

What to Watch in Public Finance, Higher Education, Infrastructure, Democracy, and Contraceptive Choice and Access for 2024
Federal Tax Policy
What to Watch in Public Finance, Higher Education, Infrastructure, Democracy, and Contraceptive Choice and Access for 2024
Look Ahead
Commercial Sector Prices
Paying a Site-Neutral Rate for Off-Campus Outpatient Departments Could Save Billions

State Policy Win Snapshot: Texas and Connecticut Fight Anti-Competitive Hospital Practices
Commercial Sector Prices
State Policy Win Snapshot: Texas and Connecticut Fight Anti-Competitive Hospital Practices
State Policy Win Snapshot
Clinical Trials
AV Submits Letter on Controlled Clinical Investigation and Confirmatory Evidence

23 Stories of Transformative Policymaking from 2023
Policing
23 Stories of Transformative Policymaking from 2023
Year in Review
Drug Prices
AV Submits Letter on Excise Tax on Designated Drugs

In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
Drug Prices
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment

Dual Eligible Americans Need Support During Medicare Open Enrollment
Medicare-Medicaid Integration
Dual Eligible Americans Need Support During Medicare Open Enrollment

Site-Neutral Payments Could Mean Big Savings for Patients With Chronic Conditions
Commercial Sector Prices
Site-Neutral Payments Could Mean Big Savings for Patients With Chronic Conditions

How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
How a Broken Patent System Contributes to Unaffordable Prescription Drugs

New Opportunity for States to Improve Health Care and Slow Cost Growth
Provider Payment Incentives
New Opportunity for States to Improve Health Care and Slow Cost Growth

About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.